Boehringer Ingelheim

Jardiance cleared in EU for CKD, challenging Forxiga
Pharmaphorum
Wed, 07/26/23 - 09:45 am
Boehringer Ingelheim
Eli Lilly
Jardiance
Europe
chronic kidney disease
Forxiga
Novo Nordisk, Eli Lilly and Boehringer Ingelheim back bill to bring obesity drug coverage to Medicare
Fierce Pharma
Thu, 07/20/23 - 09:42 pm
Novo Nordisk
Eli Lilly
Boehringer Ingelheim
obesity
7 companies are rolling out Humira biosimilars
Drugstore News
Wed, 07/12/23 - 09:44 am
AbbVie
Humira
biosimilars
Boehringer Ingelheim
Organon
Samsung Bioepsis
Sandoz
Fresenius Kabi
Celltrion
Coherus Biosciences
Biocon
Boehringer's new data drop shows 19% weight loss for phase 2 obesity prospect
Fierce Biotech
Sun, 06/25/23 - 09:46 pm
Boehringer Ingelheim
obesity
clinical trials
Zealand Pharma
survodutide
Sanofi says arbitration court rejects Boehringer's Zantac claims
Reuters
Wed, 06/21/23 - 10:53 am
Sanofi
Boehringer Ingelheim
Zantac
legal
FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes
Benzinga
Tue, 06/20/23 - 09:46 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
Synjardy
type 2 diabetes
pediatric
FDA
Late-stage pipeline for idiopathic pulmonary fibrosis is small but growing
Clinical Trials Arena
Mon, 06/19/23 - 11:39 am
IPF
Roche
Esbriet
Pirespa
Boehringer Ingelheim
Ofev
Yuhan makes $325M cancer bet to challenge Boehringer, Takeda
Fierce Pharma
Wed, 05/31/23 - 06:59 pm
Yuhan
cancer
Boehringer Ingelheim
Takeda
HER2 inhbitor
non-small cell lung cancer
Zealand, Boehringer's drug meets main weight-loss goal in mid-stage trial
BioSpace
Wed, 05/10/23 - 10:21 am
Boehringer Ingelheim
Zealand Pharma
obesity
clinical trials
BI 456906
Boehringer Ingelheim to Mine Ginkgo’s Molecules in $406M Undruggable Targets Deal
BioSpace
Mon, 05/8/23 - 11:30 pm
Boehringer Ingelheim
Ginko Bioworks
bioactive molecules
Boehringer Ingelheim to surf with Melbourne-based biotech in $181M neuropsychiatric therapy deal
Fierce Biotech
Fri, 05/5/23 - 11:53 am
Boehringer Ingelheim
Kinoxis Therapeutics
neuropsychiatric
Boehringer Ingelheim breaks ground on €285M API plant in Germany
Fierce Pharma
Wed, 05/3/23 - 11:35 am
Boehringer Ingelheim
drug manufacturing
Germany
Boehringer Ingelheim opens new biotechnology R&D center in Germany
Pharmaceutical Business Review
Tue, 04/25/23 - 10:42 am
Boehringer Ingelheim
Germany
R&D
Playing catch-up, Boehringer taps RetinAI for AI boost to eye disease R&D
Fierce Biotech
Fri, 04/21/23 - 10:14 am
Boehringer Ingelheim
RetinAI
artificial intelligence
geographic atrophy
R&D
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CP Wire
Mon, 04/3/23 - 03:35 pm
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
Mon, 04/3/23 - 03:33 pm
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Boehringer signals intent in obesity
EP Vantage
Thu, 03/30/23 - 10:05 am
Boehringer Ingelheim
Zealand Pharma
obesity
clinical trials
BI 456906
Boehringer Ingelheim and Eli Lilly's Jardiance gets big lift from heart failure indications
Fierce Pharma
Wed, 03/29/23 - 04:01 pm
Boehringer Ingelheim
Eli Lilly
Jardiance
heart failure
Covant and Boehringer Ingelheim Collaborate to Develop a Novel ADAR1 Inhibitor for Use in Cancer Patients
Marketscreener
Tue, 03/28/23 - 10:20 am
Covant Therapeutics
drug discovery
R&D
Boehringer Ingelheim
cancer
ADAR1
Big-sellers from Merck, Novo and Lilly likely to face Medicare price negotiations: report
Fierce Pharma
Tue, 02/28/23 - 10:39 pm
Medicare
drug pricing
Merck
Novo Nordisk
Eli Lilly
Boehringer Ingelheim
JNJ

Pages